Using the specific blockers of Ca2+ channels, pumps and/or exchangers has demonstrated the significant antitumor effects on lung cancer progression (Table 2), indicating that Ca2+ signaling would be a promising target for novel lung cancer treatments. This evidence concerns the gene CA2 and lung carcinoma.